Cargando…

In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions

Leprosy is a complex chronic, infectious dermato-neurological disease that affects the skin and peripheral nerves especially during immuno-inflammatory episodes known as type 1/T1R and type 2/T2R reactions. This study investigated the in situ expression of CD25(+)Foxp3(+) T(reg) cells and TGF-β1, IF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Maurício Barcelos, Hungria, Emerith Mayra., Freitas, Aline Araújo., Sousa, Ana Lúcia O. M., Jampietro, Juliano, Soares, Fernando A., Stefani, Mariane M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993234/ https://www.ncbi.nlm.nih.gov/pubmed/29883464 http://dx.doi.org/10.1371/journal.pone.0196853

Ejemplares similares

Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions
por: Mizoguti, Danielle de Freitas, et al.
Publicado: (2015)

Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology
por: Paula Vaz Cardoso, Ludimila, et al.
Publicado: (2013)

Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR)
por: Hungria, Emerith Mayra, et al.
Publicado: (2017)

Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil
por: Hungria, Emerith Mayra, et al.
Publicado: (2016)

Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report
por: Stefani, Mariane M, et al.
Publicado: (2009)

Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT
por: Hungria, Emerith M., et al.
Publicado: (2018)

Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases
por: Stefani, Mariane M. A., et al.
Publicado: (2017)

PERFIL CLÍNICO-EPIDEMIOLÓGICO DOS ATENDIMENTOS RELACIONADOS A COVID-19 NUM HOSPITAL DE REFERÊNCIA DE ANÁPOLIS/GO
por: Daher, Marcelo Cecilio, et al.
Publicado: (2022)

Leprosy survey among rural communities and wild armadillos from Amazonas state, Northern Brazil
por: Stefani, Mariane Martins Araújo, et al.
Publicado: (2019)

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization
Publicado: (1989)

Cytokine Levels in Neural Pain in Leprosy
por: Angst, Débora Bartzen Moraes, et al.
Publicado: (2020)

In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin
por: Bahia El Idrissi, Nawal, et al.
Publicado: (2017)

Th17 Cells and Cytokines in Leprosy: Understanding the Immune Response and Polarization
por: Zaniolo, Larissa Marchi, et al.
Publicado: (2023)

Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
por: Penna, Gerson Oliveira, et al.
Publicado: (2017)

One Case of Tuberculosis-Like Leprosy with a Type I Leprosy Reaction
por: Li, Jie, et al.
Publicado: (2023)

Serum levels of inflammatory cytokines in leprosy patients
por: de Paula, Lúcia, et al.
Publicado: (2010)

Inflammatory cytokines in leprosy reactions and periodontal diseases
por: Cortela, Denise Costa Boamorte, et al.
Publicado: (2018)

Teaching of leprosy: current challenges()
por: Alves, Cynthia Rossetti Portela, et al.
Publicado: (2014)

Human Genetic Susceptibility of Leprosy Recurrence
por: Uaska Sartori, Priscila Verchai, et al.
Publicado: (2020)

A novel integrated molecular and serological analysis method to predict new cases of leprosy amongst household contacts
por: Gama, Rafael Silva, et al.
Publicado: (2019)

Assistive technologies for improving the oral hygiene of leprosy patients residing in a former leprosy colony in Betim, Minas Gerais, Brazil
por: Ferreira, Raquel Conceição, et al.
Publicado: (2018)

Defective production of monocyte-activating cytokines in lepromatous leprosy
Publicado: (1984)

Role of HLA, KIR, MICA, and Cytokines Genes in Leprosy
por: Jarduli, Luciana Ribeiro, et al.
Publicado: (2013)

Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy
por: Goulart, Isabela Maria Bernardes, et al.
Publicado: (2022)

Neutrophil extracellular traps contribute to the pathogenesis of leprosy type 2 reactions
por: da Silva, Camila Oliveira, et al.
Publicado: (2019)

Prediction of the occurrence of leprosy reactions based on Bayesian networks
por: de Andrade Rodrigues, Rafael Saraiva, et al.
Publicado: (2023)

Nose and Throat Lesions in Cases of Leprosy of the Lepromatous Type
por: Ghosh, K. K., et al.
Publicado: (1951)

Electrophysiological Study of Nerves in Type-II Reaction in Leprosy
por: Singh, Santosh Kumar, et al.
Publicado: (2017)

Type I Interferons, Autophagy and Host Metabolism in Leprosy
por: Toledo Pinto, Thiago Gomes, et al.
Publicado: (2018)

In Situ Cytokine Expression and Morphometric Evaluation of Total Collagen and Collagens Type I and Type III in Keloid Scars
por: da Silva, Isabela Rios, et al.
Publicado: (2017)

Virus-vector relationship in the Citrus leprosis pathosystem
por: Tassi, Aline Daniele, et al.
Publicado: (2017)

Bullous Type Ii Reaction in Leprosy: A Diagnostic Dillemma
por: Kar, Bikash Ranjan, et al.
Publicado: (2013)

Type 2 leprosy reaction with Sweet's syndrome-like presentation
por: Chiaratti, Francielle Chiavelli, et al.
Publicado: (2016)

Type I Lepra Reaction as the Presenting Sign of Histoid Leprosy
por: Sun, Jingru, et al.
Publicado: (2017)

Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin
por: Santos, Mônica, et al.
Publicado: (2013)

Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach
por: Cruz, Rossilene Conceição da Silva, et al.
Publicado: (2018)

Altered cytokine profiles in relapsed paucibacillary leprosy: a case report
por: Sameshima, Tomoyuki, et al.
Publicado: (2021)

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
por: Soares, Cleverson T., et al.
Publicado: (2018)

Trends of main indicators of leprosy in Brazilian municipalities with high risk of leprosy transmission, 2001–2012
por: Freitas, Lucia R. S., et al.
Publicado: (2016)

Development and Validation of a Severity Scale for Leprosy Type 1 Reactions
por: Walker, Stephen L., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_cadn1tp09bnf53n5cugro10a4d